Translational Development Acquisition annual ebitda
2023
2024
2025
Translational Development Acquisition EBITDA Growth & History (TDAC)
Translational Development Acquisition's calculated EBITDA was −$944,538 for fiscal 2025.
View full Translational Development Acquisition company overviewTranslational Development Acquisition annual ebitda history
| Fiscal year | Period ended | EBITDA | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | −$944,538 | −$748,180 | — |
| 2024 | 2024-12-31 | −$196,358 | $289,192 | — |
| 2023 | 2023-12-31 | −$485,550 | — | — |
Translational Development Acquisition quarterly ebitda
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | EBITDA | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | −$661,050 | −$439,923 | — |
| Q1 2026 | 2026-03-31 | −$281,161 | $66,247 | — |
| Q4 2025 | 2025-12-31 | −$162,345 | — | — |
| Q3 2025 | 2025-09-30 | −$213,658 | — | — |
| Q2 2025 | 2025-06-30 | −$221,127 | — | — |
| Q1 2025 | 2025-03-31 | −$347,408 | — | — |
Translational Development Acquisition ebitda trends
Between the periods ended 2023-12-31 and 2025-12-31, Translational Development Acquisition's ebitda decreased from −$485,550 to −$944,538, a change of −$458,988. The latest reported quarter, Q2 2026, shows −$661,050.
About the metric
What EBITDA means
EBITDA is a measure of operating performance before interest, taxes, depreciation, and amortization. It can help compare operating results, but it is not a substitute for cash flow or GAAP net income.
Calculation and source
How TickerStat calculates EBITDA
TickerStat calculates EBITDA as operating income plus reported depreciation and amortization for aligned fiscal periods. It is calculated data, not adjusted EBITDA or company guidance. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Translational Development Acquisition source filings ↗